Aβ regulation-based multitarget strategy for drug discovery against Alzheimer’s disease

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Reviews in the Neurosciences

• Publication date

  2015-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1515/revneuro-2014-0064PMID 25720054
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Faculty Opinions recommendation of Imaging markers for Alzheimer disease: which vs how.

  2017cited by this paper
• Inflammatory risk factors and pathologies promoting Alzheimer's disease progression: is RAGE the key?

  2015cited by this paper
• Deaths in the United States among persons with Alzheimer's disease (2010–2050)

  2014cited by this paper
• Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study.

  2014cited by this paper
• Everolimus: a new hope for patients with breast cancer

  2014cited by this paper
• Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents.

  2014cited by this paper
• Review - Part of the Special Issue: Alzheimer's Disease - Amyloid, Tau and Beyond Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers

  2014cited by this paper
• Potassium 2-(1-Hydroxypentyl)-Benzoate Improves Memory Deficits and Attenuates Amyloid and τ Pathologies in a Mouse Model of Alzheimer's Disease

  2014cited by this paper
• Meserine, a Novel Carbamate AChE Inhibitor, Ameliorates Scopolamine‐Induced Dementia and Alleviates Amyloidogenesis of APP/PS1 Transgenic Mice

  2014cited by this paper
• Clinical trials and late‐stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

  2014cited by this paper
• Targeting the β secretase BACE1 for Alzheimer's disease therapy.

  2014cited by this paper
• Design, synthesis and evaluation of novel tacrine-rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease.

  2014cited by this paper
• Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

  2014cited by this paper
• Combotherapy and current concepts as well as future strategies for the treatment of Alzheimer’s disease

  2014influential reference
• Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies.

  2014cited by this paper
• Contribution of Alzheimer disease to mortality in the United States

  2014cited by this paper
• Targeting the mTOR Signaling Network for Alzheimer’s Disease Therapy

  2013cited by this paper
• Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's disease

  2013cited by this paper
• Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of BACE Inhibitor LY2886721 in Healthy Volunteers (HVs) at Steady State (P01.017)

  2013cited by this paper
• mTOR is a key modulator of ageing and age-related disease

  2013cited by this paper
• Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells

  2013cited by this paper
• Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.

  2013cited by this paper
• 2013 Alzheimer's disease facts and figures

  2013cited by this paper
• Latrepirdine (Dimebon®), a potential Alzheimer therapeutic, regulates autophagy and neuropathology in an Alzheimer mouse model

  2013cited by this paper
• Therapeutic induction of autophagy to modulate neurodegenerative disease progression

  2013cited by this paper
• Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease

  2013cited by this paper
• Arctigenin Effectively Ameliorates Memory Impairment in Alzheimer's Disease Model Mice Targeting Both β-Amyloid Production and Clearance

  2013cited by this paper
• Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer’s disease transgenic mouse model

  2013cited by this paper
• Structural Biology of Presenilins and Signal Peptide Peptidases*

  2013cited by this paper
• Multipotent, permeable drug ASS234 inhibits Aβ aggregation, possesses antioxidant properties and protects from Aβ-induced apoptosis in vitro.

  2013cited by this paper
• A phase 3 trial of semagacestat for treatment of Alzheimer's disease.

  2013cited by this paper
• PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease.

  2013cited by this paper
• Semagacestat, a γ‐secretase inhibitor, activates the growth hormone secretagogue (GHS‐R1a) receptor

  2013cited by this paper
• Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012

  2013cited by this paper
• The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinoma

  2013cited by this paper
• Alzheimer's disease and diabetes: new insights and unifying therapies.

  2013cited by this paper
• Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease

  2012cited by this paper
• Molecular mechanism aspect of ER stress in Alzheimer's disease: current approaches and future strategies.

  2012cited by this paper
• Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review

  2012cited by this paper
• Oxidant Stress and Signal Transduction in the Nervous System with the PI 3-K, Akt, and mTOR Cascade

  2012cited by this paper
• New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties.

  2012cited by this paper
• Lifelong rapamycin administration ameliorates age‐dependent cognitive deficits by reducing IL‐1β and enhancing NMDA signaling

  2012cited by this paper
• Alzheimer mechanisms and therapeutic strategies.

  2012influential reference
• A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.

  2012cited by this paper
• Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.

  2012cited by this paper
• Glycation‐altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age‐related disease (in nondiabetics)

  2012cited by this paper
• Mitochondrial Dysfunction—A Pharmacological Target in Alzheimer's Disease

  2012cited by this paper
• Mammalian target of rapamycin: A valid therapeutic target through the autophagy pathway for alzheimer's disease?

  2012cited by this paper
• mTOR signaling in growth control and disease.

  2012cited by this paper
• Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells.

  2012cited by this paper
• JNK3 perpetuates metabolic stress induced by Aβ peptides.

  2012cited by this paper
• Aβ Toxicity in Alzheimer's Disease

  2012cited by this paper
• Evaluation of Methylation Status in the 5'UTR Promoter Region of the DBC2 Gene as a Biomarker in Sporadic Breast Cancer

  2012cited by this paper
• Alzheimer’s Disease Pathologic Cascades: Who Comes First, What Drives What

  2011cited by this paper
• Amyloid-dependent and amyloid-independent stages of Alzheimer disease.

  2011cited by this paper
• Alpha‐secretase in Alzheimer’s disease: molecular identity, regulation and therapeutic potential

  2011cited by this paper
• Multitarget-directed ligands: innovative chemical probes and therapeutic tools against Alzheimer's disease.

  2011cited by this paper
• The Amazonian herbal Marapuama attenuates cognitive impairment and neuroglial degeneration in a mouse Alzheimer model.

  2011cited by this paper
• Novel anti-Alzheimer’s dimer bis(7)-Cognitin: Cellular and molecular mechanisms of neuroprotection through multiple targets

  2011cited by this paper
• Ridaforolimus: a promising drug in the treatment of soft-tissue sarcoma and other malignancies.

  2011cited by this paper
• Multi-target-directed ligands in Alzheimer's disease treatment.

  2011cited by this paper
• AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

  2011cited by this paper
• TOR and ageing: a complex pathway for a complex process

  2011cited by this paper
• Mitochondria as a therapeutic target for aging and neurodegenerative diseases.

  2011cited by this paper
• The Loss of c-Jun N-Terminal Protein Kinase Activity Prevents the Amyloidogenic Cleavage of Amyloid Precursor Protein and the Formation of Amyloid Plaques In Vivo

  2011cited by this paper
• Increases in β-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-κB pathway activation

  2011cited by this paper
• Fighting neurodegeneration with rapamycin: mechanistic insights

  2011cited by this paper
• Activation of the α-Secretase Processing of AβPP as a Therapeutic Approach in Alzheimer's Disease

  2011cited by this paper
• Memoquin: A multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer’s disease

  2011cited by this paper
• Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease

  2011cited by this paper
• Revisiting the cholinergic hypothesis in the development of Alzheimer's disease.

  2011cited by this paper
• Acetylcholinesterase inhibition in cognition-relevant brain areas of mice treated with a nootropic Amazonian herbal (Marapuama).

  2010cited by this paper
• l-3-n-Butylphthalide Improves Cognitive Impairment and Reduces Amyloid-β in a Transgenic Model of Alzheimer's Disease

  2010cited by this paper
• Neuroinflammation in Alzheimer's Disease: Are NSAIDs and Selective COX-2 Inhibitors the Next Line of Therapy?

  2010cited by this paper
• Faculty Opinions recommendation of Autophagy protects neuron from Abeta-induced cytotoxicity.

  2010cited by this paper
• Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta‐amyloid‐induced toxicity in PC12 cells

  2010cited by this paper
• Honokiol increases ABCA1 expression level by activating retinoid X receptor beta.

  2010cited by this paper
• Clinical studies with sirolimus, zotarolimus, everolimus, and biolimus A9 drug-eluting stent systems.

  2010cited by this paper
• Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.

  2010cited by this paper
• Baicalein protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis through inhibition of reactive oxygen species production and CHOP induction

  2010cited by this paper
• Tacrine derivatives and Alzheimer's disease.

  2010cited by this paper
• Doxycycline and minocycline for the management of acne: a review of efficacy and safety with emphasis on clinical implications.

  2010cited by this paper
• Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease

  2010cited by this paper
• Dimebon (Latrepirdine) Enhances Mitochondrial Function and Protects Neuronal Cells from Death

  2010cited by this paper
• mTOR regulation of autophagy

  2010cited by this paper
• ATP-binding Cassette Transporter A1 Mediates the Beneficial Effects of the Liver X Receptor Agonist GW3965 on Object Recognition Memory and Amyloid Burden in Amyloid Precursor Protein/Presenilin 1 Mice*

  2010cited by this paper
• National Institutes of Health State-of-the-Science Conference Statement: Preventing Alzheimer Disease* and Cognitive Decline

  2010cited by this paper
• 2,2′,4′‐Trihydroxychalcone from Glycyrrhiza glabra as a new specific BACE1 inhibitor efficiently ameliorates memory impairment in mice

  2010cited by this paper
• Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of alpha-secretase and BACE-1 concurrently.

  2009cited by this paper
• Autophagy mediates pharmacological lifespan extension by spermidine and resveratrol

  2009cited by this paper
• Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease

  2009cited by this paper
• Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein γ-Secretase for the Treatment of Alzheimer's Disease

  2009cited by this paper
• Memory improvement in ibotenic acid induced model rats by extracts of Scutellaria baicalensis.

  2009cited by this paper
• The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus.

  2009cited by this paper
• L-3-n-butylphthalide improves cognitive impairment induced by intracerebroventricular infusion of amyloid-beta peptide in rats.

  2009cited by this paper
• Rapamycin fed late in life extends lifespan in genetically heterogeneous mice

  2009cited by this paper
• Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine

  2008cited by this paper
• Etazolate, a neuroprotective drug linking GABAA receptor pharmacology to amyloid precursor protein processing

  2008cited by this paper
• Oxidative stress hypothesis in Alzheimer's disease: a reappraisal.

  2008cited by this paper
• Cross-talk between oxidative stress and modifications of cholinergic and glutaminergic receptors in the pathogenesis of Alzheimer's disease

  2008cited by this paper

• Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease.

  2019cites this paper
• Sulfonamide derivatives as multi-target agents for complex diseases.

  2019cites this paper
• Protopanaxadiol derivative DDPU improves behavior and cognitive deficit in AD mice involving regulation of both ER stress and autophagy

  2018cites this paper
• Multi-targeting Strategies for Alzheimer's Disease Therapeutics: Pros and Cons.

  2017cites this paper
• Multitarget Anti-Alzheimer Hybrid Compounds: Do They Work In Vivo?

  2017cites this paper
• Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics.

  2016cites this paper
• Small molecule LX2343 ameliorates cognitive deficits in AD model mice by targeting both amyloid β production and clearance

  2016cites this paper
• Alzheimer's disease drug development based on Computer-Aided Drug Design.

  2016cites this paper
• Label-Free Cell Phenotypic Assays for Assessing Drug Polypharmacology.

  2016cites this paper
• Editorial (Thematic Issue: Polypharmacology in Drug Discovery).

  2016cites this paper